ERCOLINO, TONINO
 Distribuzione geografica
Continente #
NA - Nord America 1.631
EU - Europa 981
AS - Asia 270
AF - Africa 1
Totale 2.883
Nazione #
US - Stati Uniti d'America 1.627
PL - Polonia 368
SE - Svezia 174
IE - Irlanda 145
IT - Italia 137
HK - Hong Kong 86
CN - Cina 60
JO - Giordania 47
RU - Federazione Russa 29
CH - Svizzera 26
SG - Singapore 26
DE - Germania 24
GB - Regno Unito 24
FI - Finlandia 21
KR - Corea 19
BE - Belgio 13
IN - India 12
UA - Ucraina 10
VN - Vietnam 10
TR - Turchia 9
CA - Canada 4
ES - Italia 3
FR - Francia 3
NL - Olanda 2
BY - Bielorussia 1
IR - Iran 1
RO - Romania 1
SC - Seychelles 1
Totale 2.883
Città #
Warsaw 368
Fairfield 272
Chandler 159
Dublin 145
Ashburn 134
Woodbridge 132
Seattle 114
Cambridge 100
Ann Arbor 87
Houston 84
Wilmington 83
Hong Kong 54
Altamura 50
Lawrence 50
Princeton 37
Florence 33
Beijing 32
Boston 26
Buffalo 26
Jacksonville 26
Moscow 25
Bern 24
Boardman 21
San Diego 19
Seoul 19
Shanghai 17
New York 14
Singapore 14
Brussels 13
Kent 13
Medford 11
Izmir 9
Dong Ket 8
Chennai 5
Hillsboro 5
Andover 4
Bologna 4
Bremen 4
Los Angeles 4
Milan 4
Norwalk 4
Old Bridge 4
Phoenix 4
Pune 4
West Jordan 4
Chiswick 3
Prato 3
Redmond 3
Toronto 3
Barcelona 2
Brooklyn 2
Düsseldorf 2
Falls Church 2
Melito Di Napoli 2
Nanjing 2
Paris 2
Redwood City 2
Rome 2
Volketswil / Volketswil (Dorf) 2
Xi'an 2
Arezzo 1
Auburn Hills 1
Bangalore 1
Bethlehem 1
Carson 1
Costa Mesa 1
Ferentino 1
Fontebuona 1
Frankfurt am Main 1
Fucecchio 1
Gonnoscodina 1
Guangzhou 1
Hefei 1
Indianapolis 1
Langhirano 1
Lappeenranta 1
Laurel 1
London 1
Madrid 1
Nürnberg 1
Ottawa 1
Portland 1
Prescot 1
Rottofreno 1
Salerno 1
Scarperia 1
Sezze 1
Shaoxing 1
Tappahannock 1
Turin 1
Venice 1
Vibo Valentia 1
Vigevano 1
Zhengzhou 1
Totale 2.337
Nome #
Rosiglitazone Inhibits Adrenocortical Cancer Cell Proliferation by Interfering with the IGF-IR Intracellular Signaling. 242
DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: Beyond pheochromocytomas and paragangliomas 198
NEW INSIGHTS IN THE CLINICAL AND TRANSLATIONAL RELEVANCE OF miR483-5p IN ADRENOCORTICAL CANCER 195
Rosiglitazone impairs proliferation of human adrenocortical cancer: preclinical study in a xenograft mouse model. 112
15 YEARS OF PARAGANGLIOMA: Metabolism and pheochromocytoma/paraganglioma 110
Fascin-1 is a Novel Prognostic Biomarker Associated with Tumor Invasiveness in Adrenocortical Carcinoma. 107
Yeast model for evaluating the pathogenic significance of SDHB, SDHC and SDHD mutations in PHEO-PGL syndrome. 97
Adrenocortical carcinoma: the dawn of a new era of genomic and molecular biology analysis. 97
Uncommon clinical presentations of pheochromocytoma and paraganglioma in two different patients affected by two distinct novel VHL germline mutations 92
Mitochondrial function and content in Pheochromocytoma/paraganglioma of succinate dehydrogenase mutation carriers 92
Occurrence of medullary thyroid carcinoma, bronchial carcinoid tumor, and papillary thyroid carcinoma in a family bearing the RET G691S polymorphism. 89
MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma 86
DISSECTING THE ORIGIN OF INDUCIBLE BROWN FAT IN ADULT HUMANS THROUGH A NOVEL ADIPOSE STEM CELL MODEL FROM ADIPOSE TISSUE SURROUNDING PHEOCHROMOCYTOMA 85
Pheochromocytoma in rats with multiple endocrine neoplasia (MENX) shares gene expression patterns with human pheochromocytoma 82
Caratterizzazione genomica del carcinoma surrenalico 82
Head and neck paragangliomas: genetic spectrum and clinical variability in 79 consecutive patients 80
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation 75
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas 74
Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes. 74
The role of PPAR-γ system in normal and tumoral corticotroph pituitary and adrenal cells. 70
SDHx and Non-Chromaffin Tumors: A Mediastinal Germ Cell Tumor Occurring in a Young Man with Germline SDHB Mutation 66
Malignant extra-adrenal pheochromocytoma caused by an SDHB intronic variation leading to a 54-bp deletion in exon 4. 65
Germline Mutation in KIF1Bβ Gene Associated with Loss of Heterozygosity: Usefulness of Next-Generation Sequencing in the Genetic Screening of Patients with Pheochromocytoma 62
Prognostic and monitoring value of circulating tumour cells in adrenocortical carcinoma: a preliminary monocentric study. 59
PheoSeq: A Targeted Next-Generation Sequencing Assay for Pheochromocytoma and Paraganglioma Diagnostics 55
Metabolome-guided genomics to identify pathogenic variants in isocitrate dehydrogenase, fumarate hydratase, and succinate dehydrogenase genes in pheochromocytoma and paraganglioma 49
Stimulated expression of CXCL12 in adrenocortical carcinoma by the ppargamma ligand rosiglitazone impairs cancer progression 46
Clinical relevance of phenotype/genotype correlations in the diagnosis and therapy of pheochromocytomas/paragangliomas. 44
Sunitinib in the therapy of malignant paragangliomas: Report on the efficacy in a sdhb mutation carrier and review of the literature 40
A multicenter epidemiological study on second malignancy in non-syndromic pheochromocytoma/paraganglioma patients in Italy 38
Outcome and genetic analysis of patients affected by retinal capillary hemangioblastoma in von hippel lindau syndrome 37
Tumoral EPAS1 (HIF2A) mutations explain sporadic pheochromocytoma and paraganglioma in the absence of erythrocytosis. 34
Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer 34
Potential pitfalls of SDH immunohistochemical detection in paragangliomas and phaeochromocytomas harbouring germline SDHx gene mutation 32
Novel Germline PHD2 Variant in a Metastatic Pheochromocytoma and Chronic Myeloid Leukemia, but in the Absence of Polycythemia 32
Management and outcome of metastatic pheochromocytomas/paragangliomas: a monocentric experience 28
Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment 26
Hypogonadism and sexual function in men affected by adrenocortical carcinoma under mitotane therapy 19
Prognostic Value of Microscopic Tumor Necrosis in Adrenal Cortical Carcinoma 17
Hemodynamic parameters in patients undergoing surgery for pheochromocytoma/paraganglioma: a retrospective study 13
Totale 2.935
Categoria #
all - tutte 9.744
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.744


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020582 47 35 17 50 62 67 73 68 57 47 51 8
2020/2021416 33 32 43 27 34 52 21 30 42 45 28 29
2021/2022277 11 25 24 13 10 12 14 31 7 18 45 67
2022/2023766 59 174 32 46 53 111 92 31 114 9 15 30
2023/2024333 11 32 41 16 20 46 11 67 13 26 42 8
2024/202527 27 0 0 0 0 0 0 0 0 0 0 0
Totale 2.935